Overview

Properties

Applications

Our Abpromise guarantee covers the use of ab92939 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 1 µg/ml. Detects a band of approximately 30 kDa (predicted molecular weight: 30 kDa).

Target

  • Function
    Regulates vascular tubulogenesis in vivo. Inhibits platelet-derived growth factor (PDGF)-BB-induced smooth muscle cell migration and promotes endothelial cells adhesion to the substrate in vitro.
  • Sequence similarities
    Contains 2 EGF-like domains.
    Contains 1 EMI domain.
  • Cellular localization
    Secreted.
  • Information by UniProt
  • Database links
  • Alternative names
    • EGF like domain 7 antibody
    • EGF like domain containing protein 7 antibody
    • EGF like domain multiple 7 antibody
    • EGF-like protein 7 antibody
    • EGFL 7 antibody
    • EGFL7 antibody
    • EGFL7_HUMAN antibody
    • Epidermal growth factor like domain protein 7 antibody
    • Epidermal growth factor-like protein 7 antibody
    • MEGF 7 antibody
    • MEGF7 antibody
    • MGC111117 antibody
    • Multiple EGF like domain protein 7 antibody
    • Multiple EGF-like domains protein 7 antibody
    • Multiple epidermal growth factor like domain protein 7 antibody
    • Multiple epidermal growth factor-like domains protein 7 antibody
    • NEU1 antibody
    • NEU1 protein antibody
    • NOTCH4 like protein antibody
    • NOTCH4-like protein antibody
    • RP11 251M1.2 antibody
    • UNQ187/PRO1449 antibody
    • Vascular endothelial statin antibody
    • VE statin antibody
    • VE-statin antibody
    • ZNEU 1 antibody
    • ZNEU1 antibody
    see all

Images

  • Anti-EGFL7 antibody (ab92939) at 1 µg/ml + Human liver tissue lysate - total protein (ab29889) at 10 µg

    Secondary
    Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (ab97080) at 1/5000 dilution
    Developed using the ECL technique

    Performed under reducing conditions.

    Predicted band size : 30 kDa
    Observed band size : 30 kDa
    Additional bands at : 110 kDa,90 kDa. We are unsure as to the identity of these extra bands.

    Exposure time : 20 minutes

References

ab92939 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab92939.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up